Interleukin-1 Receptor-Associated Kinase 2 (IRAK2) (C-Term) Peptide
Quick Overview for Interleukin-1 Receptor-Associated Kinase 2 (IRAK2) (C-Term) Peptide (ABIN8103410)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- IRAK2 Peptide - C-terminal region
-
Sequence
- SSSEACVGLE PPQDVTETSW QIEINEAKRK LMENILLYKE EKVDSIELFG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-IRAK2 Antibody (ARP61222_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IRAK2 (Interleukin-1 Receptor-Associated Kinase 2 (IRAK2))
-
Background
-
Background Information: IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB.
Alternative Symbols: IRAK-2, MGC150550
-
Molecular Weight
- 69kDa
-
Gene ID
- 3656
-
NCBI Accession
- NP_001561
-
UniProt
- O43187
Target
-